Gisela Paulsen

2022 - Oncocyte Corp

In 2022, Gisela Paulsen earned a total compensation of $1.3M as Former President and Chief Operating Officer at Oncocyte Corp.

Compensation breakdown

Option Awards$233,738
Salary$356,426
Stock Awards$509,250
Other$241,712
Total$1,341,125

Paulsen received $509.3K in stock awards, accounting for 38% of the total pay in 2022.

Paulsen also received $233.7K in option awards, $356.4K in salary and $241.7K in other compensation.

Rankings

In 2022, Gisela Paulsen's compensation ranked 2,465th out of 5,756 executives tracked by ExecPay. In other words, Paulsen earned more than 57.2% of executives.

ClassificationRankingPercentile
All
2,465
out of 5,756
57th
Division
Manufacturing
1,353
out of 3,133
57th
Major group
Chemicals And Allied Products
611
out of 1,419
57th
Industry group
Drugs
565
out of 1,320
57th
Industry
In Vitro and In Vivo Diagnostic Substances
8
out of 29
72nd
Source: SEC filing on May 19, 2023.

Paulsen's colleagues

We found five more compensation records of executives who worked with Gisela Paulsen at Oncocyte Corp in 2022.

2022

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

2022

Douglas Ross

Oncocyte Corp

Chief Scientific Officer

2022

Anish John

Oncocyte Corp

Chief Financial Officer

2022

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

2022

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

News

You may also like